Results 201 to 210 of about 399,081 (334)
ABSTRACT This paper reports on the excavation of a cache of stone artefacts, buried on the bank of a waterhole or ‘billabong’ in central western Queensland. This is an extremely rare find, and yet it is the second such site to be reported within less than a 10 km radius.
Yinika L. Perston +5 more
wiley +1 more source
Optimisation of Using Low-Grade Kaolinitic Clays in Limestone Calcined Clay Cement Production (LC3). [PDF]
Vargas P +6 more
europepmc +1 more source
Secondary energy component in energy-saving processes of cement production
О. А. Панова +4 more
openalex +1 more source
ABSTRACT Saruq al‐Hadid, located at the edge of the Rub Al‐Khali desert near Dubai's southern border with Abu Dhabi, is among the region's richest archaeological sites. Renowned for its historical role in metallurgy, trade and human habitation, the site was occupied from the Umm an‐Nar period through the post–Iron Age. Despite its significance, much of
Moamen Ali +9 more
wiley +1 more source
Efficient Management of Asbestos Waste Through Utilization as Mineral Additives in Portland Cement Production. [PDF]
Durczak K +5 more
europepmc +1 more source
Backyard seed production of pearl spot (Etroplus suratensis) in FRP/cement tanks using river water: A case study from Chengannur, Kerala [PDF]
Smina MS, Shoji Joseph, Ajithkumar PB
openalex +1 more source
Abstract Language is a major source of systemic inequities in science, particularly among scholars whose first language is not English. Studies have examined scientists' linguistic practices in specific contexts; few, however, have provided a global analysis of multilingualism in science. Using two major bibliometric databases (OpenAlex and Dimensions),
Carolina Pradier +2 more
wiley +1 more source
Geological evaluation of black shale as a suitable Supplementary Cementitious Material (SCM) to optimize the use of clinker in cement production. [PDF]
Nunoo S +9 more
europepmc +1 more source
Small and mid‐sized pharmaceutical innovators often have limited in‐house health economics and market access expertise, and may struggle to align development strategies of investigational medicinal products with health system needs and payer expectations.
Zoltán Kaló +5 more
wiley +1 more source

